News

Video briefing on the day's top infectious disease news.

Given research into SARS-CoV-2 is taking place at unprecedented speed, the panel of IDSA experts had to decide on current best practices using science which is still in motion.

New research shows microorganisms on this part of the body may be able to diagnose chronic heart failure.

In a small randomized trial, Greek investigators found patients had improved time to clinical deterioration versus a control group.

Patrick Soon-Shiong, MD, Chairman and CEO of ImmunityBio, explains why the firm's COVID-19 research benefits from drawing on a background in cancer.

A recent review of electronic health data revealed a 42% drop in emergency department visits during 4 weeks of the pandemic.

RSV-associated lower respiratory infections affect tens of millions of children and kill more than 100,000 children each year. A new vaccine candidate is showing promise in protecting against the disease.

An overview of today's top infectious disease stories.

Patrick Soon-Shiong, MD, CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.

Finch Therapeutics announced its investigational oral microbiome drug, CP101, reached a sustained clinical cure in its Phase 2 trial.

Data were published using the International Symposium on Pneumococci and Pneumococcal Diseases online digital library.

A video summary of the latest infectious disease headlines.

Company’s anti-infective agent sees setback related to COVID-19.

With the current COVID-19 outbreak, new data about Influenza mortality related to spectator sports should make the professional leagues and fans pause about attending games.

Compared to 2019, out-of-hospitalization cardiac arrest resuscitations saw a dramatic increase as well as differences in the types of patients experiencing these episodes.

Broad-spectrum antimicrobial therapy is common among critically ill patients, but few undergo antimicrobial de-escalation, a new study found.

Findings reveal that most unhealthy seniors and/or their families opt for comfort-directed care rather than life-sustaining treatment.

A new report from the CDC finds refugees arriving in the United States who are infected with hepatitis B virus are frequently lost to follow-up care.

An overview of FDA drug pipeline news from the past week.

The week's FDA recall updates.

A June 19, 2020 recap of the biggest headlines in pandemic research and response.

A telephone survey confirms people are dealing with these issues and suggests it may be an early bellwether to providers and patients alike.

Although routinely prescribed after surgery, a new meta-analysis of studies on antibiotics and surgery finds there is no need for post-surgery antibiotics if best practices are followed.

In a recent US survey, African American male participants knew more people infected with COVID-19, had greater knowledge disparities, and were exposed to the virus more than other groups.

Health officials are urging parents to adhere to recommended vaccination schedules amid the COVID-19 pandemic, which has led to a drop in vaccination coverage.

A video review of the latest ID news.

Pregnant women with COVID-19 typically experienced symptoms in their second and third trimester, a new study shows.

Vibeke Strand, MD, MACR, FACP, of the Division of Immunology/Rheumatology at Stanford University School of Medicine, discusses ongoing AI research in her field.